Exelixis
EXEL
#1697
Rank
NZ$17.02 B
Marketcap
$59.63
Share price
0.52%
Change (1 day)
70.11%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $84.31 NZD on 2000-07-26

Lowest end of day price: $2.21 NZD on 2014-12-24

Stock price history of Exelixis from 2000 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$57.69 1.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
$82.14 0.42%๐Ÿ‡ซ๐Ÿ‡ท France
$170.95 2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
$99.68 0.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$496.28 0.71%๐Ÿ‡บ๐Ÿ‡ธ USA
$266.20 1.56%๐Ÿ‡บ๐Ÿ‡ธ USA
$43.02 0.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.02 10.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.68 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA